Suppr超能文献

母体注射促甲状腺激素释放激素后的羊水促甲状腺激素(TSH)

Amniotic fluid thyrotropin (TSH) following maternal administration of thyrotropin releasing hormone.

作者信息

Robuschi G, Braverman L E, Emanuele R, d'Amato L, Gardini E, Foscolo M S, Gualerzi C, Benassi L, Gnudi A, Roti E

出版信息

J Perinat Med. 1985;13(5):219-26. doi: 10.1515/jpme.1985.13.5.219.

Abstract

Cord blood and amniotic fluid thyrotropin (TSH), T4, T3, and rT3 concentrations were measured in 49 women who received 400 micrograms thyrotropin releasing hormone (TRH) iv during labor and in 16 control women who received saline. Cord blood serum TSH concentrations were elevated for as long as 4 hours after TRH administration and peak values (38.0 +/- 4.2 microU/ml) were observed from 61-120 minutes after TSH as compared to control values of 5.0 +/- 0.3 microU/ml. The elevations in fetal TSH concentration stimulated the fetal thyroid, resulting in a progressive increase in cord blood T4 and T3 but not rT3 concentrations. These TRH induced elevations in fetal cord blood TSH concentrations were not accompanied by increases in unconcentrated and 4 fold concentrated amniotic fluid TSH concentrations which were almost always below 0.6 microU/ml, the limit of assay sensitivity. Unconcentrated amniotic fluid T4 concentrations were barely detectable and no variation was observed between the TRH treated and saline treated mothers; amniotic fluid T3 was not detectable in any of the groups; and amniotic fluid rT3 concentrations ranged between 46.4 and 55.6 ng/dl and did not differ between groups. These findings suggest that term amniotic fluid TSH values do not reflect transient but marked elevations in fetal serum TSH concentrations and that amniotic fluid TSH determination is probably not useful in the detection of primary fetal hypothyroidism. It is possible, but unlikely, that long-term and even greater elevations in fetal serum TSH concentrations would result in increased amniotic fluid TSH concentrations.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对49名在分娩期间静脉注射400微克促甲状腺激素释放激素(TRH)的女性以及16名接受生理盐水注射的对照女性,测定了脐血和羊水促甲状腺激素(TSH)、甲状腺素(T4)、三碘甲状腺原氨酸(T3)和反三碘甲状腺原氨酸(rT3)的浓度。与对照值5.0±0.3微国际单位/毫升相比,TRH给药后脐血血清TSH浓度升高长达4小时,并在给药后61至120分钟观察到峰值(38.0±4.2微国际单位/毫升)。胎儿TSH浓度的升高刺激了胎儿甲状腺,导致脐血T4和T3浓度逐渐升高,但rT3浓度未升高。这些由TRH诱导的胎儿脐血TSH浓度升高,并未伴随未浓缩和4倍浓缩羊水TSH浓度的升高,后者几乎总是低于0.6微国际单位/毫升,即检测灵敏度的极限。未浓缩羊水T4浓度几乎无法检测到,TRH治疗组和生理盐水治疗组母亲之间未观察到差异;任何组中均未检测到羊水T3;羊水rT3浓度在46.4至55.6纳克/分升之间,各组之间无差异。这些发现表明,足月羊水TSH值不能反映胎儿血清TSH浓度的短暂但显著升高,羊水TSH测定可能对原发性胎儿甲状腺功能减退症的检测无用。胎儿血清TSH浓度长期甚至更大幅度的升高有可能导致羊水TSH浓度升高,但可能性不大。(摘要截短至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验